FibroBiologics (STU:SG0) Long-Term Capital Lease Obligation : €1.18 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Long-Term Capital Lease Obligation?

FibroBiologics's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €1.18 Mil.

FibroBiologics's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (€1.36 Mil) to Dec. 2023 (€1.27 Mil) and declined from Dec. 2023 (€1.27 Mil) to Mar. 2024 (€1.18 Mil).

FibroBiologics's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€1.65 Mil) but then declined from Dec. 2022 (€1.65 Mil) to Dec. 2023 (€1.27 Mil).

FibroBiologics Long-Term Capital Lease Obligation Historical Data

The historical data trend for FibroBiologics's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Long-Term Capital Lease Obligation Chart

FibroBiologics Annual Data

Trend

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

1.65

1.27

FibroBiologics Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial				-	1.43	1.36	1.27	1.18

FibroBiologics (STU:SG0) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

FibroBiologics Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (STU:SG0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

FBLG:USA

Address

455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598

Website

https://www.fibrobiologics.com

FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines